Psilocybin for CH - EROWID

download: 'file:mushrooms-erowid/mushrooms_EROWID.pdf'
url: 'http://www.erowid.org'
noticetext: 'Poster session material showing efficacy of Psilocybin and LSD for CH'
excerpt: "ABSTRACT:\nOBJECTIVE: TO DESCRIBE THE USE OF PSILOCYBIN AND LYSERGIC ACID DIETHYLAMIDE (LSD) FOR TREATMENT \nOF CLUSTER HEADACHE. \nMETHODS: PATIENTS, RECRUITED BY ONLINE INTERNET SURVEYS AND INTEREST GROUPS, WERE \nQUESTIONED ABOUT THEIR USE OF PSILOCYBIN AND LSD TO TREAT THEIR CLUSTER HEADACHES. OF 383 \nPATIENTS IDENTIFIED, 53 CONSENTED TO INTERVIEWS AND PROVIDED MEDICAL RECORDS. \nRESULTS: 52 PARTICIPANTS HAD USED PSILOCYBIN AND NINE HAD USED \nLSD TO TREAT THEIR CLUSTER HEADACHES. TWENTY-TWO (85%) OF 26 \nPSILOCYBIN USERS REPORTED THAT PSILOCYBIN HAD ABORTED ATTACKS; 25 \n(52%) OF 48 PSILOCYBIN USERS AND SEVEN (88%) OF 8 LSD USERS REPORTED \nTERMINATION OF AT LEAST ONE CLUSTER PERIOD; AND 18 (95%) OF 19 \nPSILOCYBIN USERS AND FOUR (80%) OF FIVE LSD USERS REPORTED EXTENSION \nOF THEIR REMISSION PERIOD. TWENTY-TWO (42%) PSILOCYBIN USERS AND \nTWO (22%) LSD USERS EXPERIENCED THERAPEUTIC \nEFFECTS WITH SUB-HALLUCINOGENIC DOSES. \nCONCLUSIONS: LSD AND PSILOCYBIN MAY BE \nEFFECTIVE IN TREATING CLUSTER ATTACKS, \nTERMINATING CLUSTER PERIODS AND EXTENDING \nREMISSIONS, POSSIBLY BY A MECHANISM UNRELATED \nTO THEIR HALLUCINOGENIC PROPERTIES"

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License